Salix contacts Actavis over potential sale-source
NEW YORK, Sept 24 (Reuters) - Salix Pharmaceuticals Ltd has had contact with Actavis Plc about a potential sale to the larger drugmaker, as it continues discussions with Allergan Inc about selling itself, according to a person familiar with the matter.
Allergan has revived discussions to buy Salix in recent weeks after on-and-off talks for nearly a year, as it tries to fend off a hostile offer from Valeant Pharmaceuticals Inc , Reuters reported earlier this week.
CNBC reported earlier Wednesday that Salix was in early-stage discussions with Actavis.
Representatives for Salix and Actavis could not be immediately reached for comment. (Reporting by Olivia Oran in New York; Editing by Bernadette Baum)
© Thomson Reuters 2017 All rights reserved.